These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5382940)
1. [Sense and nonsense of antivaricose agents]. Salfeld K Z Haut Geschlechtskr; 1969 Sep; 44(18):713-26. PubMed ID: 5382940 [No Abstract] [Full Text] [Related]
3. [Multicentric controlled test of a new antivaricose agent in general practice]. Meyer HR Praxis; 1967 Mar; 56(12):424-8. PubMed ID: 4867334 [No Abstract] [Full Text] [Related]
4. [Treatment of venopathies of the lower extremities]. Schröder E Z Allgemeinmed; 1969 Aug; 45(22):1040-2. PubMed ID: 5817718 [No Abstract] [Full Text] [Related]
5. [Experiences with a topical therapeutic agent against varicose veins]. Schön J; Wefers J Hippokrates; 1968 Mar; 39(6):227-8. PubMed ID: 5752072 [No Abstract] [Full Text] [Related]
6. [Varicose veins in pregnancy and their treatment using butylsympatol]. Acuña Díaz G Rev Colomb Obstet Ginecol; 1968; 19(2):117-24. PubMed ID: 4391528 [No Abstract] [Full Text] [Related]
7. [Endothelial dysfunction in patients with lower-limb varicose disease and possibilities of correction thereof]. Shevchenko IuL; Stoĭko IuM; Gudymovich VG; Nikitina AM; Trifonov SI Angiol Sosud Khir; 2010; 16(4):99-104. PubMed ID: 21389952 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacologic properties of bioflavonoids]. Lecomte J; Van Cauwenberge H Rev Med Liege; 1971 Oct; 26(20):673-81. PubMed ID: 4948615 [No Abstract] [Full Text] [Related]
9. [Methodology for quality control of an ointment with antivaricose properties]. Lazăr D; Lazăr MI; Verbuţă A; Dănilă G; Oiţă N Rev Med Chir Soc Med Nat Iasi; 1992; 96(3-4):253-6. PubMed ID: 1344865 [TBL] [Abstract][Full Text] [Related]
10. [Internal treatment of chronic venous insufficiency. Clinico-pharmacological studies]. Tronnier H Munch Med Wochenschr; 1968 Oct; 110(40):2303-7. PubMed ID: 4998528 [No Abstract] [Full Text] [Related]
11. [Action of trioxyethylrutin on capillary resistance and venous disorders in pregnant women]. Laforet J; Lansac J; Gaja R Lyon Med; 1969 Nov; 222(41):901-3. PubMed ID: 5383281 [No Abstract] [Full Text] [Related]
12. [On drug therapy of the varicose symptom complex]. Grethen-Bussmann P Hippokrates; 1966 Jan; 37(2):71-2. PubMed ID: 5913586 [No Abstract] [Full Text] [Related]
13. [Varicose symptom complex; diseases of the locomotor system; blunt trauma]. Heynen U Z Allgemeinmed; 1969 May; 45(13):629-32. PubMed ID: 5801656 [No Abstract] [Full Text] [Related]
14. [What can the physician expect from "venotropic" drugs?]. Stemmer R Phlebologie; 1970; 23(3):251-63. PubMed ID: 5475591 [No Abstract] [Full Text] [Related]
15. [Influence of venoruton injectabile and compression on the varicose sympton complex with reference to capillary resistance and capillary permeability]. Gerlach E Med Monatsschr; 1968 Sep; 22(9):414-20. PubMed ID: 5702823 [No Abstract] [Full Text] [Related]
16. [Supplemental effect of beta-aescin by vasodilator agents]. Schrümpf E Wien Med Wochenschr; 1969 Oct; 119(42):721-2. PubMed ID: 4391303 [No Abstract] [Full Text] [Related]
17. [A new antivaricose drug in the varicose symptom complex and in hemorrhoids]. Müller HK Med Klin; 1968 May; 63(18):724-7. PubMed ID: 5719911 [No Abstract] [Full Text] [Related]
18. [Capillary permeability in the objective evaluation of a venotonic agent]. Gounon P Phlebologie; 1980; 33(3):569-74. PubMed ID: 7413766 [No Abstract] [Full Text] [Related]
19. [The principles of action and use of phlebotropic agents]. Kharkevich DA Klin Med (Mosk); 2004; 82(11):4-10. PubMed ID: 15656390 [No Abstract] [Full Text] [Related]
20. [The saluretic furosemide in the treatment of sequelae of venous insufficiency]. Jänner M Munch Med Wochenschr; 1965 Jul; 107(29):1420-3. PubMed ID: 5897507 [No Abstract] [Full Text] [Related] [Next] [New Search]